MHC class I molecules and KIRS in human history, health and survival

Nature Reviews Immunology

Volumn 5, Issue 3, 2005, Pages 201-214

  Parham, Peter ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; INFECTION RESISTANCE; INNATE IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIGENE FAMILY; NATURAL KILLER CELL; POPULATION GROWTH; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REPRODUCTION; REVIEW; T LYMPHOCYTE;

ANIMALS; AUTOIMMUNE DISEASES; COMMUNICABLE DISEASES; EVOLUTION, MOLECULAR; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LYMPHOCYTES; MODELS, IMMUNOLOGICAL; NEOPLASMS; RECEPTORS, IMMUNOLOGIC;

EID: 14944355535     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1570     Document Type: Review

References (124)

1. Gumperz, J. E. & Parham, P. The enigma of the natural killer cell. Nature 378, 245-248 (1995).
2. Kasahara, M., Suzuki, T. & Du Pasquier, L. On the origins of the adaptive immune system: novel insights from invertebrates and cold-blooded vertebrates. Trends Immunol. 25, 105-111 (2004).
3. Pancer, Z. et al. Somatic diversification of variable lymphocyte receptors in the agnathan sea lamprey. Nature 430, 174-180 (2004).
4. Flajnik, M. F. & Du Pasquier, L. Evolution of innate and adaptive immunity: can we draw a line? Trends Immunol. 25, 640-644 (2004).
5. Veinotte, L. L., Wilhelm, B. T., Mager, D. L. & Takei, F. Acquisition of MHC-specific receptors on murine natural killer cells. Crit. Rev. Immunol. 23, 251-266 (2003).
6. Moretta, L. & Moretta, A. Unravelling natural killer cell function: triggering and inhibitory human NK receptors. EMBO J. 23, 255-259 (2003).
7. Raulet, D. H. Interplay of natural killer cells and their receptors with the adaptive immune response. Nature Immunol. 5, 996-1002 (2004).
8. Chien, Y.-H., Jores, R. & Crowley, M. P. Recognition by γδ cells. Annu. Rev. Immunol. 14, 511-532 (1996).
9. Snyder, M. R., Weyand, C. M. & Goronzy, J. J. The double life of NK receptors: stimulation or co-stimulation? Trends Immunol. 25, 25-32 (2004). A thorough up-to-date review of NK-cell-receptor expression by T cells.
10. Kasahara, M. The chromosomal duplication model of the major histocompatibility complex. Immunol. Rev. 167, 17-32 (1999).
11. Weil, A. Mammalian evolution: onwards and upwards. Nature 416, 798-799 (2002).
12. Mestas, J. & Hughes, C. C. W. Of mice and not men: differences between mouse and human immunology. J. Immunol. 172, 2731-2738 (2004). A short review that begins serious discussion in print about the fact (of which immunologists seem to be in collective denial) that there are considerable differences between the human immune system and that of the favoured animal model, the mouse.
13. Trowsdale, J. & Parham, P. Defense strategies and immunity-related genes. Eur. J. Immunol. 34, 7-17 (2004).
14. Trowsdale, J. T. Genetic and functional relationships between MHC and NK receptor genes. Immunity 15, 363-374 (2001).
15. Anderson, S. K., Ortaldo, J. R. & McVicar, D. W. The ever-expanding Ly49 gene family: repertoire and signaling. Immunol. Rev. 181, 79-89 (2002).
16. Vilches, C. & Parham, P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217-251 (2002).
17. Yokohama, W. M. & Plougastel, B. F. Immune functions encoded by the natural killer gene complex. Nature Rev. Immunol. 4, 304-316 (2003).
18. Martin, A. M., Kulski, J. K., Witt, C., Pontarotti, P. & Christiansen, F. T. Leukocyte Ig-like receptor complex (LRC) in mice and men. Trends Immunol. 23, 81-88 (2002).
19. Wilhelm, B. T. & Mager, D. L. Rapid expansion of the Ly49 gene cluster in rat. Genomics 84, 218-221 (2004).
20. Proteau, M.-F., Rousselle, E. & Makrigiannis A. P. Mapping of the BALB/c Ly49 cluster defines a minimal natural killer cell receptor gene repertoire. Genomes 84, 669-677 (2004). Comparison of three mouse Ly49 haplotypes shows how the overall organization of the Ly49 locus is similar to the human KIR locus.
21. Mager, D. L., McQueen, K. L., Wee, V. & Freeman, J. D. Evolution of natural killer cell receptors: coexistence of functional Ly49 and KIR genes in baboons. Curr. Biol. 11, 626-630 (2001).
22. Welch, A. Y., Kasahara, M. & Spain, L. M. Identification of the mouse killer immunoglobulin-like (Kirl) gene family mapping to chromosome X. Immunogenetics 54, 782-790 (2003).
23. Hoelsbrekken, S. E. et al. Molecular cloning of a killer cell Ig-like receptor in the mouse and rat. J. Immunol. 170, 2259-2263 (2003).
24. Daza-Vamenta, R., Glusman, G., Rowen, L., Guthrie, B. & Geraghty, D. E. Genetic divergence of the rhesus macaque major histocompatibility complex. Genome Res. 8, 1501-1515 (2004). This genomic analysis, which describes the complete sequence of an MHC class I region from the rhesus monkey and compares it with the human counterpart, exemplifies the magnitude of change that is possible in gene families of the immune system within relatively short periods of evolutionary time.
25. Kulski, J. K., Anzai, T., Shiina, T. & Inoko, H. Rhesus macaque class I duplicon structures, organization and evolution within the α block of the major histocompatibility complex. Mol. Biol. Evol. 21, 2079-2091 (2004).
26. LaBonte, M. L., Hershberger, K. L., Korber, B. & Letvin, N. L. The KIR and CD94/NKG2 families of molecules in the rhesus monkey. Immunol. Rev. 183, 25-40 (2001).
27. Sambrook, J. G. et al. Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates. Genome Res. 15, 25-35 (2005).
28. Stewart, C. A. et al. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14, 1176-1187 (2004).
29. Adams, E. J., Thomson, G. & Parham, P. Evidence for an HLA-C-like locus in the orangutan Pongo pygmaeus. Immunogenetics 49, 865-871 (1999).
30. Colonna, M., Boresellino, G., Falco, M., Ferrara, G. B. & Strominer, J. L. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl Acad. Sci. USA 90, 12000-12004 (1993). This paper describes the discovery of the C1 and C2 motifs of HLA-C as the genetic factors that determine the specificity of two types of alloreactive NK cell.
31. Khakoo, S. I. et al. Rapid evolution of NK cell receptor systems demonstrated by comparison of chimpanzees and humans. Immunity 12, 687-698 (2000).
32. Guethlein, L. A., Flodin, L. R., Adams, E. J. & Parham, P. NK cell receptors of the orangutan (Pongo pygmaeus): a pivotal species for tracking the coevolution of killer cell Ig-like receptors with MHC-C. J. Immunol. 169, 220-229 (2002).
33. Boyington, J. C. & Sun, P. D. A structural perspective on MHC class I recognition by killer cell immunoglobulin-like receptors. Mol. Immunol. 38, 1007-1021 (2001). An insightful and informed review of the structural biology of the KIR-HLA class I interaction.
34. Moretta, A. et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182, 875-884 (1995).
35. Biassoni, R. et al. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. Eur. J. Immunol. 27, 3095-3099 (1997).
36. Vales-Gomez, M., Reyburn, H. T., Erskine, R. A. & Strominger, J. L. Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. Proc. Natl Acad. Sci. USA 95, 14326-14331 (1998).
37. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O. & Wagtmann, N. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161, 571-577 (1998).
38. Saulquin, X., Gastinel, L. N. & Vivier, E. Crystal structure of the human natural killer activating receptor KIR2DS2 (CD158j). J. Exp. Med. 197, 933-938 (2003).
39. Wan, A. M., Ennis, P., Parham, P. & Holmes, N. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes. J. Immunol. 137, 3671-3674 (1986).
40. Cella, M., Longo, A., Ferrara, G. B., Strominger, J. L. & Colonna, M. NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242 (1994).
41. Gumperz, J. E., Litwin, V., Phillips, J. H., Lanier, L. L. & Parham, P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J. Exp. Med. 181, 1133-1144 (1995).
42. Adams, E. J. and Parham, P. Species-specific evolution of MHC class I genes in the higher primates. Immunol. Rev. 183, 41-64 (2001).
43. Gardiner, C. M. et al. Different NK cell surface phenotypes defined by the DX9 antibody are due to KIR3DL1 polymorphism. J. Immunol. 166, 2992-3001 (2001).
44. Uhrberg, M. et al. Human diversity in killer cell inhibitory receptor genes. Immunity 7, 753-763 (1997). This paper describes the discovery of the variation and diversity in gene content of human KIR haplotypes and the existence of the group A and group B KIR haplotypes.
45. Wilson, M. J. et al. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl Acad. Sci. USA 97, 4778-4783 (2000).
46. Shilling, H. G. et al. Allelic polymorphism synergizes with variable gene content to individualize human KIR genotype. J. Immunol. 168, 2307-2315 (2002).
47. Marsh, S. G. E. et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Immunogenetics 55, 220-226 (2003).
48. Moffett-King, A. Natural killer cells and pregnancy. Nature Rev. Immunol. 2, 656-663 (2002).
49. Lopez-Botet, M., Angulo, A. & Guma, M. Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. Tissue Antigens 63, 195-203 (2004).
50. Brown, D., Trowsdale, J. & Allen, R. The LILR family: modulators of innate and adaptive immune pathways in health and disease. Tissue Antigens 64, 215-225 (2004).
51. Rajagopalan, S. & Long, E. O. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189, 1093-1100 (1999).
52. Witt, C. S. et al. Alleles of the KIR2DL4 receptor and their lack of association with pre-eclampsia. Eur. J. Immunol. 32, 18-29 (2002).
53. Gomez-Lozano, N., de Pablo, R., Puente, S. & Vilches, C. Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur. J. Immunol. 33, 639-644 (2003).
54. Hiby, S. E. et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965 (2004). This comparison of maternal and fetal KIR and HLA genotypes in normal and pre-eclamptic pregnancies shows that the combination of maternal homozygosity for group A KIR haplotypes and fetal HLA-C2 predisposes women to pre-eclampsia. These authors also discovered the inverse correlation between the frequencies of group A KIR haplotypes and HLA-C2 in human populations.
55. Varla-Leftherioti, M. et al. Natural killer (NK) cell receptors' repertoire in couples with recurrent spontaneous abortions. Am. J. Reprod. Immunol. 49, 183-191 (2003).
56. Lanier, L. L. Natural killer cell receptor signaling. Curr. Opin. Immunol. 15, 308-314 (2003).
57. Leibson, P. J. The regulation of lymphocyte activation by inhibitory receptors. Curr. Opin. Immunol. 16, 328-336 (2004). References 56 and 57 provide an excellent introduction to NK-cell-receptor signalling, a subject not covered in the current review.
58. Yawata, M. et al. Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 54, 543-550 (2002).
59. Ashkar, A. A., Di Santo, J. P. & Croy, B. A. Interferon γ contributes to initiation of uterine vascular modification, decidual integrity and uterine natural killer maturation during normal pregnancy. J. Exp. Med. 192, 259-270 (2000). Although placental anatomy differs between humans and mice, the abundance of NK cells in the uterine wall is a common feature. Genetically modified mice that lack NK cells manage to reproduce, but in pregnancy, there is poor remodelling of the vasculature that supplies the fetus with blood. This inadequacy can be remedied simply by injecting the mice with IFN-γ, a cytokine that is characteristically produced by NK cells.
60. Khakoo, S. I. et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874 (2004). This epidemiological analysis of cohorts of HCV-infected individuals from the United States and the United Kingdom found that resolution of an acute infection is favoured in individuals who are homozygous for both KIR2DL3 and HLA-C1. This was the first paper to report a disease association with an inhibitory KIR.
61. Orange, J. S. Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4, 1545-1558 (2002). The most comprehensive review of human NK-cell deficiencies.
62. Moretta, A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nature Rev. Immunol. 2, 957-964 (2002).
63. Martin, M. P. et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nature Genet. 31, 429-434 (2002).
64. Hansasuta, P. et al. Recognition of HLA-A3 and HLA-A11 by KIR3DL2 is peptide-specific. Eur. J. Immunol. 34, 1673-1679 (2004). This binding analysis shows that KIR3DL2 has a binding specificity that is more similar to an αβ TCR than those of the HLA-B-specific KIR3DL1 and the HLA-C-specific KIR2DL1, KIR2DL2 and KIR2DL3. KIR3DL2 binds HLA-A3 and HLA-A11 but only when they are bound to a specific peptide, the known example being a peptide derived from Epstein-Barr virus.
65. Artavanis-Tsakonas, K. et al. Activation of a subset of human NK cells upon contact with Plasmodium falciparum-infected erythrocytes. J. Immunol. 171, 5396-5405 (2003).
66. Sagoo, G. S. et al. Meta-analysis of genome-wide studies of psoriasis susceptibility reveals linkage to chromosomes 6p21 and 4q28-31 in Caucasian and Chinese Hans population. J. Invest. Dermatol. 122, 1401-1405 (2004).
67. Luszczek, W, et al. Gene for the activating natural killer cell receptor, KIR2DS1, is associated with susceptibility to psoriasis vulgaris. Hum. Immunol. 65, 758-766 (2004).
68. Suzuki, Y. et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J. Invest. Dermatol. 122, 1133-1136 (2004).
69. Martin, M. P. et al. Susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles. J. Immunol. 169, 2818-2822 (2002).
70. Nelson, G. W. et al. Heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis. J. Immunol. 173, 4273-4276 (2004).
71. van der Slik, A. R. et al. KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52, 2639-2642 (2003).
72. Momot, T. et al. Association of killer cell immunoglobulin-like receptors with scleroderma. Arthritis Rheum. 50, 1561-1565 (2004).
73. Yen, J. H. et al. Major histocompatibility complex class I-recognizing receptors are disease risk genes in rheumatoid arthritis. J. Exp. Med. 193, 1159-1168 (2001).
74. Poszepczynska-Guigne, E. et al. CD158K/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome. J. Invest. Dermatol. 122, 820-823 (2004).
75. - lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell lymphoproliferative disease of granular lymphocytes. Br. J. Haematol. 126, 55-62 (2004).
76. Pascal, V. et al. Comparative analysis of NK cell subset distribution in normal and lymphoproliferative disease of granular lymphocyte conditions. Eur. J. Immunol. 34, 2930-2940 (2004).
77. Epling-Burnette, P. K. et al. Dysregulated NK receptor expression in patients with lymphoproliferative disease of granular lymphocytes. Blood 103, 3431-3439 (2004).
78. Zambello, R. et al. Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood 102, 1797-1805 (2003).
79. Warren, H. S., Christiansen, F. T. & Witt, C. S. Functional inhibitory human leukocyte antigen class I receptors on natural killer (NK) cells in patients with chronic NK lymphocytosis. Br. J. Haematol. 121, 793-804 (2003).
80. Morice, W. G., Kurtin, P. J., Leibson, P. J., Tefferi, A. & Hanson, C. A. Demonstration of aberrant T-cell and natural-killer cell antigen expression in all cases of granular lymphocytic leukaemia. Br. J. Haematol. 120, 1028-1036 (2003).
81. Uhrberg, M. et al. The repertoire of KIR and CD94:NKG2A receptors in T cells: clones sharing identical αβ TCR rearrangements express highly diverse KIR patterns. J. Immunol. 166, 3923-3932 (2001).
82. Vely, F. et al. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166, 2487-2494 (2001).
83. null T cells clonally expanded in rheumatoid arthritis. J. Immunol. 168, 3839-3846 (2002).
84. Verheyden, S., Bernier, M. & Demanet, C. Identification of natural killer cell phenotypes associated with leukemia. Leukemia 18, 2002-2007 (2004).
85. Parham, P. & McQueen, K. L. Alloreactive killer cells: hindrance and help for haematopoietic transplants. Nature Rev. Immunol. 3, 108-122 (2003).
86. Ruggeri, L. et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100 (2002). This paper shows how alloreactive NK cells can improve the outcome of haploidentical transplantation for leukaemia by preventing GVHD and relapse. Historically, haploidentical transplantation has had a poor prognosis, but publication of this paper has stimulated a reconsideration of its potential applications.
87. Giebel, S. et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102, 814-819 (2003).
88. Leung, W. et al. Determinants of antileukemia effects of allogeneic NK cells. J. Immunol. 172, 644-650 (2004). NK-cell alloreactions are usually considered to arise when an allogeneic target cell lacks an inhibitory MHC class I molecule that is a ligand for the NK cells of the donor. In this situation, the NK cells seem to recognize the missing self-MHC class I molecule. The authors propose that, under the perturbed conditions that exist after a haematopoietic stem-cell transplant, there can be transient alloreactions that do not conform to 'missing-self' recognition; these are anticipated when the stem-cell donor has an inhibitory HLA-specific KIR for which the recipient has no matching inhibitory HLA class I molecule. This approach emphasizes the matching of cognate ligands with receptors and not the differences between one set of ligands and another. It is the same concept that is used to analyse the NK-cell reactions in pregnancy, a situation to which missing self does not pertain.
89. Dupont, B. & Hsu, K. C. Inhibitory killer Ig-like receptor genes and human leukocyte class I ligands in haematopoietic stem cell transplantation. Curr. Opin. Immunol. 16, 634-643 (2004).
90. Bishara, A. et al. The beneficial role of inhibitory KIR genes of HLA class INK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 63, 204-211 (2004).
91. Davies, S. M. et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Blood 100, 3825-3827 (2002).
92. Schaffer, M., Malmberg, K.-J., Ringden, O., Ljunggren, H.-G. & Remberger, M. Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation 78, 1081-1085 (2004).
93. Bornhauser, M. et al. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 103, 2860-2861 (2004).
94. Gagne, K. et al. Relevance of KIR gene polymorphisms in bone marrow transplantation outcome. Hum. Immunol. 63, 271-280 (2002).
95. Cook, M. A. et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 15, 1521-1526 (2004).
96. Uhrberg, M., Parham, P. & Wernet, P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven genes. Immunogenetics 54, 221-229 (2002).
97. Hsu, K. C. et al. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169, 5118-5129 (2002).
98. Grau, R., et al. Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self HLA class I molecules against autologous hematopoietic stem cells in healthy individuals. Exp. Mol. Pathol. 76, 90-98 (2004).
99. Valiante, N. M. et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751 (1997).
100. Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520-562 (2002).
101. Hsu, K. C., Chida, S., Geraghty, D. E. & Dupont, B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190, 40-52 (2002).
102. Yawata, M., Yawata, N., Abi-Rached, L. & Parham, P. Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit. Rev. Immunol. 22, 463-482 (2002).
103. Halfpenny, I. A., Middleton, D., Barnett, Y. A. & Williams, F. Investigation of killer cell immunoglobulin-like receptor gene diversity: IV. KIR3DL1/S1. Hum. Immunol. 65, 602-612 (2004).
104. Martin, M. P., Basirova, A., Traherne, J., Trowsdale, J. & Carrington, M. Expansion of the KIR locus by unequal crossing over. J. Immunol. 171, 2192-2195 (2003).
105. Gomez-Lozano, N. et al. The silent KIR3DP1 gene (CD158c) is transcribed and might encode a secreted receptor in a minority of humans, in whom the KIR3DP7, KIR2DL4 and KIR3DL1/KIR3DS1 genes are duplicated. Eur. J. Immunol. 35, 16-24 (2005).
106. Goodridge, J. P., Witt, C. S., Christiansen, F. T. & Warren, H. S. KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J. Immunol. 171, 1768-1774 (2003).
107. Kikuchi-Maki, A., Yusa, S.-I., Catina, T. L. & Campbell, K. S. KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-γ production. J. Immunol. 171, 3415-3425 (2003).
108. Faure, M. & Long, E. O. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168, 6208-6214 (2002).
109. Maxwell, L. D., Wallace, A., Middleton, D. & Curran, M. D. A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60, 254-258 (2002).
110. Pando, M. J., Gardiner, C. M., Gleimer, M., McQueen, K. L. & Parham, P. The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1. J. Immunol. 171, 6640-6649 (2003).
111. + cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33, 3439-3447 (2003).
112. Belkin, D. et al. Killer cell Ig-like receptor and leukocyte Ig-like receptor transgenic mice exhibit tissue- and cell-specific transgene expression. J. Immunol. 171, 3056-3063 (2003).
113. Stewart, C. A., van Bergen, B. & Trowsdale, J. T. Different and divergent regulation of the KIR2DL4 and KIR3DL1 promoters. J. Immunol. 170, 6073-6081 (2003).
114. Trompeter, H.-I. et al. Three structurally and functionally divergent kinds of promoter regulate expression of clonally distributed KIR, of KIR2DL4 and KIR3DL3. J. Immunol. (in the press).
115. Santourlidis, S. et al. Crucial role of DNA methylation in determination of clonally distributed killer cell Ig-like receptor expression patterns in NK cells. J. Immunol. 169, 4253-4261 (2002).
116. Chan, H.-W. et al. DNA methylation maintains allele-specific KIR gene expression in human natural killer cells. J. Exp. Med. 197, 245-255 (2003).
117. Shilling, H. G. et al. Genetic control of human NK cell repertoire. J. Immunol. 169, 239-247 (2002).
118. Snyder, M. R., Nakajima, T., Leibson, P. J., Weyand, C. M. & Goronzy, J. J. Stimulatory killer Ig-like receptors modulate T cell activation through DAP12-dependent and DAP12-indepenent mechanisms. J. Immunol. 173, 3725-3731 (2004).
119. Martin, A. M. et al. Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B. Gene 335, 121-131 (2004).
120. Takahashi, T. et al. Natural killer cell receptors in the horse: evidence for the existence of multiple transcribed LY49 genes. Eur. J. Immunol. 34, 773-784 (2004).
121. Storset, A. K., Slettedal, I. O., Williams, J. L., Law, A. & Dissen, E. Natural killer cell receptors in cattle: a bovine killer cell immunoglobulin-like receptor multigene family contains members with divergent signaling motifs. Eur. J. Immunol. 33, 980-990 (2003).
122. Gagnier, L., Wilhelm, B. T. & Mager, D. L. Ly49 genes in non-rodent mammals. Immunogenetics 55, 109-115 (2003).
123. Rajalingam, R., Parham P. & Abi-Rached, L. Domain shuffling has been the main mechanism forming new hominoid killer cell Ig-like receptors. J. Immunol. 172, 356-369 (2004).
124. Rajalingam, R. et al. Short KIR haplotypes in pygmy chimpanzee (Bonobo) resemble the conserved framework of diverse human KIR haplotypes. J. Exp. Med. 193, 135-146 (2001).